These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1424 related articles for article (PubMed ID: 17041749)
1. Indication and benefit of pelvic sidewall dissection for rectal cancer. Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054 [TBL] [Abstract][Full Text] [Related]
3. [Clinic study of lateral lymph node metastasis in advanced lower rectal cancer]. Wu ZY; Wan J; Yao Y; Zhao G; Du JL; Yang J Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):190-2. PubMed ID: 18683713 [TBL] [Abstract][Full Text] [Related]
4. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period. Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974 [TBL] [Abstract][Full Text] [Related]
5. Who can get the beneficial effect from lateral lymph node dissection for Dukes C rectal carcinoma below the peritoneal reflection? Sato H; Maeda K; Maruta M; Masumori K; Koide Y Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S3-12. PubMed ID: 17106812 [TBL] [Abstract][Full Text] [Related]
6. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results]. Kneist W; Heintz A; Wolf HK; Junginger T Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030 [TBL] [Abstract][Full Text] [Related]
7. Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. Hida J; Yasutomi M; Fujimoto K; Maruyama T; Okuno K; Shindo K J Am Coll Surg; 1997 May; 184(5):475-80. PubMed ID: 9145067 [TBL] [Abstract][Full Text] [Related]
8. What factors affect lymph node yield in surgery for rectal cancer? Thorn CC; Woodcock NP; Scott N; Verbeke C; Scott SB; Ambrose NS Colorectal Dis; 2004 Sep; 6(5):356-61. PubMed ID: 15335370 [TBL] [Abstract][Full Text] [Related]
9. [Lateral pelvic lymph node metastasis is an important prognostic factor for low rectal cancer]. Pan YS; Wan YL; Liu YC; Wang X; Wu T Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):984-7. PubMed ID: 19957807 [TBL] [Abstract][Full Text] [Related]
10. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166 [TBL] [Abstract][Full Text] [Related]
11. Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes. Liang JT; Huang KC; Lai HS; Lee PH; Sun CT Ann Surg Oncol; 2007 Jul; 14(7):1980-90. PubMed ID: 17458586 [TBL] [Abstract][Full Text] [Related]
12. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261 [TBL] [Abstract][Full Text] [Related]
13. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer. Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501 [TBL] [Abstract][Full Text] [Related]
14. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection]. Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079 [TBL] [Abstract][Full Text] [Related]
15. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y; Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948 [TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650 [TBL] [Abstract][Full Text] [Related]
17. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence. Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181 [TBL] [Abstract][Full Text] [Related]
18. Lateral lymph node dissection for lower rectal cancer. Shiozawa M; Akaike M; Yamada R; Godai T; Yamamoto N; Saito H; Sugimasa Y; Takemiya S; Rino Y; Imada T Hepatogastroenterology; 2007 Jun; 54(76):1066-70. PubMed ID: 17629040 [TBL] [Abstract][Full Text] [Related]
19. Metastasis to the sigmoid or sigmoid mesenteric lymph nodes from rectal cancer. Park IJ; Choi GS; Lim KH; Kang BM; Jun SH Ann Surg; 2009 Jun; 249(6):960-4. PubMed ID: 19474698 [TBL] [Abstract][Full Text] [Related]
20. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Ueno M; Oya M; Azekura K; Yamaguchi T; Muto T Br J Surg; 2005 Jun; 92(6):756-63. PubMed ID: 15838895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]